MoneyWorks4Me

Revenue reduced marginally to stand at Rs. 1825.70 millions during the quarter ended June 2025. The figure stood at Rs. 1856.40 millions during the year-ago period.Net profit stood at Rs. 858.90  millions  compared to Rs. 725.40 millions in the corresponding previous quarter,high by 18.40%.Operating profit for the quarter ended June 2025 rose to 1186.40 millions as compared to 1028.80 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1825.70 1856.40 -1.65 1825.70 1856.40 -1.65 7524.10 6250.90 20.37
Other Income 320.30 215.00 48.98 320.30 215.00 48.98 1345.90 1058.40 27.16
PBIDT 1186.40 1028.80 15.32 1186.40 1028.80 15.32 4665.60 3929.20 18.74
Interest 0.40 0.20 100.00 0.40 0.20 100.00 1.20 1.00 20.00
PBDT 1186.00 1028.60 15.30 1186.00 1028.60 15.30 4664.40 3928.20 18.74
Depreciation 61.40 61.80 -0.65 61.40 61.80 -0.65 247.70 270.80 -8.53
PBT 1124.60 966.80 16.32 1124.60 966.80 16.32 4416.70 3657.40 20.76
TAX 265.70 241.40 10.07 265.70 241.40 10.07 1021.80 820.30 24.56
Deferred Tax -3.40 -4.30 -20.93 -3.40 -4.30 -20.93 -7.20 -40.90 -82.40
PAT 858.90 725.40 18.40 858.90 725.40 18.40 3394.90 2837.10 19.66
Equity 152.00 152.00 0.00 152.00 152.00 0.00 152.00 151.90 0.07
PBIDTM(%) 64.98 55.42 17.26 64.98 55.42 17.26 62.01 62.86 -1.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..